Dosing with recombinant factor viia based on current evidence
- 1 January 2004
- journal article
- review article
- Published by Elsevier in Seminars in Hematology
- Vol. 41, 35-39
- https://doi.org/10.1053/j.seminhematol.2003.11.008
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIXJournal of Thrombosis and Haemostasis, 2003
- Mechanism of factor VIIa–dependent coagulation in hemophilia bloodBlood, 2002
- Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic proceduresHaemophilia, 2001
- The effect of factor X level on thrombin generation and the procoagulant effect of activated factor VII in a cell-based model of coagulationBlood Coagulation & Fibrinolysis, 2000
- Clinical Use of Recombinant FVIIa (rFVIIa)Transfusion Science, 1998
- Factor VIIa in the treatment of haemophiliaBlood Coagulation & Fibrinolysis, 1990
- SUCCESSFUL USE OF RECOMBINANT FACTOR VIIa IN PATIENT WITH SEVERE HAEMOPHILIA A DURING SYNOVECTOMYThe Lancet, 1988
- Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors.Journal of Clinical Investigation, 1983
- Evaluation of a New Concentrate for the Treatment of Factor IX DeficiencyNew England Journal of Medicine, 1969
- CONGENITAL SPCA DEFICIENCY: A HITHERTO UNRECOGNIZED COAGULATION DEFECT WITH HEMORRHAGE RECTIFIED BY SERUM AND SERUM FRACTIONS 1Journal of Clinical Investigation, 1951